- Report
- January 2026
- 181 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 188 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 177 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 194 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- October 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- October 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2607EUR$3,000USD£2,269GBP
- Report
- November 2025
- 185 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- January 2026
- 185 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- May 2025
- 196 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- August 2025
- 136 Pages
Global
From €3475EUR$3,999USD£3,025GBP
- Report
- October 2025
- 160 Pages
Global
From €3433EUR$3,950USD£2,988GBP
- Report
- October 2025
- 100 Pages
United States
From €5171EUR$5,950USD£4,501GBP
- Report
- July 2025
- 82 Pages
United States
From €3042EUR$3,500USD£2,647GBP
- Report
- May 2025
- 120 Pages
Global
From €5171EUR$5,950USD£4,501GBP
- Report
- August 2025
- 183 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 184 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more